Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Vaccines

Free Subscription 15.12.2025 2 Arch Virol 1 BMC Pediatr 4 BMJ 3 Clin Infect Dis 1 Clin Microbiol Rev 1 J Immunol 2 J Infect Dis 1 J Pediatr 2 Lancet 1 MMWR Morb Mortal Wkly Rep 1 N Engl J Med 2 Pediatr Infect Dis J 1 PLoS Med 7 PLoS One 41 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Virol

1. CHAI Y, Hu Z
   Adaptive immune response of poultry to Newcastle disease vaccines.
   Arch Virol. 2025;171:14.
   PubMed         Abstract available
   
   
2. JAMOUR P, Babaeimarzangou SS, Daneshvar Hosseini N, Gholizadeh Gigloo M, et al
   Immunogenetic insights into matching bivalent inactivated Payavax G79(R) for sustainable poultry vaccination against NDV-GVII and H9N2.
   Arch Virol. 2025;171:13.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

3. PEREIRA PLG, Rodrigues GJC, Ferraz ML, Souza MD, et al
   Spatial analysis of meningococcal c vaccination coverage in children in BRAZIL between 2012 and 2024.
   BMC Pediatr. 2025 Dec 7. doi: 10.1186/s12887-025-06305.
   PubMed         Abstract available
   
   

   
   BMJ

4. BARANIUK C
   Why is this year's flu season so bad, and should you get the vaccine?
   BMJ. 2025;391:r2602.
   PubMed        
   
   
5. HAYWOOD J, Weil B, Nutland W, McSorley J, et al
   Public health lessons in equity for the United Kingdom's gonorrhoea vaccine launch.
   BMJ. 2025;391:e086660.
   PubMed        
   
   
6. MAHASE E
   Vaccine hesitancy: Chris Whitty says non-judgmental patient conversations needed to counter disinformation in UK.
   BMJ. 2025;391:r2569.
   PubMed        
   
   
7. TANNE JH
   US vaccination: Hepatitis jab changes for newborns as Trump orders review of entire childhood schedule.
   BMJ. 2025;391:r2588.
   PubMed        
   
   

   
   Clin Infect Dis

8. MACHIDA M, Fukushima W
   Vaccine Policy Pendulum: a Lesson from Japan.
   Clin Infect Dis. 2025 Dec 11:ciaf689. doi: 10.1093.
   PubMed        
   
   
9. BRASSINGTON E, Fairhead C, Hill A
   Is it time to reassess the target age of HPV vaccination globally?
   Clin Infect Dis. 2025 Dec 9:ciaf679. doi: 10.1093.
   PubMed         Abstract available
   
   
10. LODHA L, Gupta S, Ashwini MA, Chandel S, et al
    Rabies Despite Post-Exposure Prophylaxis in High-Burden Settings: Vaccine Failure or Gaps in Healthcare Delivery?
    Clin Infect Dis. 2025 Dec 6:ciaf662. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Clin Microbiol Rev

11. KALIMUDDIN S, Chia PY, Low JG, Ooi EE, et al
    Dengue and severe dengue.
    Clin Microbiol Rev. 2025;38:e0024424.
    PubMed         Abstract available
    
    

    
    J Immunol

12. LOPEZ ZAPANA PA, Shook LL, Joughin BA, Jasset OJ, et al
    Maternal proteome profiling reveals dynamic gestational age-specific responses to de novo vaccination.
    J Immunol. 2025 Dec 12:vkaf298. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect Dis

13. DAULAGALA P, Leung YWY, Luk LLH, Ho F, et al
    Anti-neuraminidase antibody responses in older adults after consecutive vaccinations with enhanced influenza vaccines: a randomized controlled trial.
    J Infect Dis. 2025 Dec 8:jiaf616. doi: 10.1093.
    PubMed         Abstract available
    
    
14. SOWERS SB, Nguyen HQ, Masters NB, Mercader S, et al
    Durability of the Mumps Antibody Response After the Third Dose of MMR Vaccine.
    J Infect Dis. 2025 Dec 8:jiaf520. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Pediatr

15. OSTMAN M, Stene LC, Tapia G, Kivela L, et al
    Risk of Celiac Disease Before and After Nationwide Infant Rotavirus Vaccination: A Population-Based Study.
    J Pediatr. 2025 Dec 10:114938. doi: 10.1016/j.jpeds.2025.114938.
    PubMed         Abstract available
    
    

    
    Lancet

16. HAEUSER E, Hay SI, Mosser JF
    Population size and vaccination rates for zero-dose estimates - Authors' reply.
    Lancet. 2025;406:2627-2628.
    PubMed        
    
    
17. KUMARI N, Shridevi K, Katkuri S, Subudhi S, et al
    Population size and vaccination rates for zero-dose estimates.
    Lancet. 2025;406:2626-2627.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

18. IRVING SA, Rowley EAK, Chickery S, Natarajan K, et al
    Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:607-614.
    PubMed         Abstract available
    
    

    
    N Engl J Med

19. NEUZIL KM
    Current and Emerging Approaches to Evaluating Influenza Vaccine Performance.
    N Engl J Med. 2025;393:2361-2362.
    PubMed        
    
    

    
    Pediatr Infect Dis J

20. TAGARRO A, Gastesi I, Hotterbeekx A, Aguilera-Alonso D, et al
    Short- and Long-term Humoral Response of Immunosuppressed Children to SARS-CoV-2 BNT162b2 Vaccine.
    Pediatr Infect Dis J. 2025 Dec 5. doi: 10.1097/INF.0000000000005042.
    PubMed         Abstract available
    
    
21. SUTCLIFFE CG, Sergent VM, Azarian T, Becenti LR, et al
    Pneumococcal Carriage Among Indigenous Children in the Southwest United States in 2022-2023.
    Pediatr Infect Dis J. 2026;45:89-95.
    PubMed         Abstract available
    
    

    
    PLoS Med

22. GOTTLIEB SL, Rees H, Peters RPH
    Vaccines to prevent bacterial sexually transmitted infections: Promise, progress, and public health potential.
    PLoS Med. 2025;22:e1004849.
    PubMed         Abstract available
    
    

    
    PLoS One

23. COSTA T
    The impossible confounder: Quantifying the limits of alternative explanations for COVID-19 vaccine effectiveness.
    PLoS One. 2025;20:e0336063.
    PubMed         Abstract available
    
    
24. FREY LJ, Banasiewicz KE, Ruckes C, Wagner I, et al
    Complications and oncologic outcome in bladder cancer patients receiving radical cystectomy after intravesical instillation treatment.
    PLoS One. 2025;20:e0337644.
    PubMed         Abstract available
    
    
25. COUDERT JF, Dadachova E, Maignant G, Jonathan S, et al
    Radon exposure and COVID-19 mortality in pre-vaccination period: What links might exist?
    PLoS One. 2025;20:e0337320.
    PubMed         Abstract available
    
    
26. ELMANZLAWEY M, Terra M, Baklola M, Ahmed Y, et al
    Awareness, knowledge, and beliefs about Human Papillomavirus and its vaccine among Egyptian medical students: A cross-sectional national study.
    PLoS One. 2025;20:e0337411.
    PubMed         Abstract available
    
    
27. MACIEL PS, Almeida GG, Carvalho GBF, Silva-Pereira RAD, et al
    Exploring the immune responses triggered by vaccine formulations containing the recombinant Schistosoma mansoni 14kDa fatty acid-binding protein.
    PLoS One. 2025;20:e0338310.
    PubMed         Abstract available
    
    
28. SADEH S, Ghaemi A, Soleimani NA, Moghbeli M, et al
    Designing influenza virus-derived cell-penetrating peptides for antigen delivery: Integrating uptake efficiency, safety, and receptor targeting.
    PLoS One. 2025;20:e0338028.
    PubMed         Abstract available
    
    
29. HUSSEIN M, Gebreal A, Naeem A, AboElela AM, et al
    Cross-national disparities in healthcare workers' perceptions: Examining fear of infection and confidence in the received COVID-19 vaccines amid emerging variants.
    PLoS One. 2025;20:e0318788.
    PubMed         Abstract available
    
    

    
    Vaccine

30. REITER PL, Katz ML
    Vaccine hesitancy among midlife and older adults in the United States.
    Vaccine. 2025;72:128054.
    PubMed         Abstract available
    
    
31. JIANG J, Lam KF, Lau EHY, Yin G, et al
    Learning from the omicron BA.4/5 dominance: Strategies for future vaccination preparedness.
    Vaccine. 2025;71:128058.
    PubMed         Abstract available
    
    
32. CHANG CY, Nasreen S, Sadarangani M, Cragg JJ, et al
    Effect of pneumococcal conjugate vaccine booster dose on prevention of invasive pneumococcal disease in British Columbia, 2003-2018.
    Vaccine. 2025;71:128066.
    PubMed         Abstract available
    
    
33. WANG XL, Xu JQ, Ye BL, Liu F, et al
    Estimating diphtheria, acellular pertussis, tetanus vaccine (DTaP) effectiveness in preventing pertussis in children aged three months to six years old in Shenzhen area, China, case control study.
    Vaccine. 2025;71:128024.
    PubMed         Abstract available
    
    
34. REEVES C, Miura SST, Chappell AR, Banaag A, et al
    Trends in influenza vaccination uptake in a universally insured population in the united states, 2017-2023.
    Vaccine. 2025;71:128052.
    PubMed         Abstract available
    
    
35. CARDOSO TL, Hartwig DD
    Recombinant chimeric proteins offer new hope to control of leptospirosis.
    Vaccine. 2026;70:128012.
    PubMed         Abstract available
    
    
36. HUANG O, Tan BF, Lu CY
    Taiwanese parental perspectives on RSV: knowledge, risks, and acceptance toward immunization.
    Vaccine. 2026;70:128005.
    PubMed         Abstract available
    
    
37. CRAMER EY, Dada AO, Onofrey S, Pearlman J, et al
    Population-based serosurveys for SARS-CoV-2 transmission 2021-2022, Massachusetts USA.
    Vaccine. 2026;69:127952.
    PubMed         Abstract available
    
    
38. MARTINEZ-PEREZ A, Galvez RI, Grifoni A, Sette A, et al
    Impact of the bivalent COVID-19 booster on spike-specific t cell responses.
    Vaccine. 2026;69:127995.
    PubMed         Abstract available
    
    
39. SHI C, Li Q, Wang S, Li R, et al
    Brucella secreted effector BspH stimulates intracellular ion flux and confers anti-Brucella immunity.
    Vaccine. 2026;69:127992.
    PubMed         Abstract available
    
    
40. KHAN MY, Aljehani ND, Abdulal RH, Ghazwani A, et al
    Intranasal CD40-targeted recombinant MERS-CoV S1 protein is superior to intramuscular immunization in eliciting systemic and mucosal immune responses in mice.
    Vaccine. 2026;69:127975.
    PubMed         Abstract available
    
    
41. DO THT, Kent SJ, Whealtey AK, Koutsakos M, et al
    Impact of serum versus anticoagulant-containing plasma on influenza virus neuraminidase-based serological assays.
    Vaccine. 2025;69:127956.
    PubMed         Abstract available
    
    
42. BALLOUT S, Darwish SA, Kelly PJ, Keller T, et al
    The use of storytelling in COVID-19 vaccine promotion: A scoping review of interventions and campaigns.
    Vaccine. 2025;72:128098.
    PubMed         Abstract available
    
    
43. WALTER EB, Schlaudecker EP, Talaat KR, Rountree W, et al
    Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trial.
    Vaccine. 2025;72:128072.
    PubMed         Abstract available
    
    
44. WOLFF E, Schollin Ask L, Larsson S
    Cost-effectiveness analyses of catch-up vaccination against human papillomavirus (HPV) related cancers of boys and young men in Sweden.
    Vaccine. 2025;72:128077.
    PubMed         Abstract available
    
    
45. ZELKOSKI AE, Mitre E, Alameh MG, Malloy AMW, et al
    Distinct innate immune activation profiles of an mRNA-lipid nanoparticle vaccine compared to the empty lipid nanoparticle.
    Vaccine. 2025;71:128061.
    PubMed         Abstract available
    
    
46. GROMIS A, Faherty LJ
    School-entry vaccine exemptions in Maine before and after public law 154, 2018-2023.
    Vaccine. 2025;71:128103.
    PubMed         Abstract available
    
    
47. PARIDANS M, Gillain N, Husson E, Darcis G, et al
    COVID-19 vaccination: Does knowledge of higher immunity influence first and second COVID-19 booster uptake? A study carried out in a university population.
    Vaccine. 2025;72:128057.
    PubMed         Abstract available
    
    
48. ZADE JK, Pisal SS, Tyagi P, Menon R, et al
    Immunogenicity and non-inferiority evaluation of dose-sparing adjuvanted inactivated polio vaccine in Wistar rats.
    Vaccine. 2025;72:128109.
    PubMed         Abstract available
    
    
49. CASWELL C, Pullenayegum E, Singh P, Ward BJ, et al
    Sex-differences in influenza vaccine efficacy and immunogenicity among Canadian Hutterite children.
    Vaccine. 2025;72:128102.
    PubMed         Abstract available
    
    
50. SONG JY, Cheong HJ
    Understanding the low effectiveness of influenza vaccines in older adults of South Korea: an exploration of contributing factors.
    Vaccine. 2025;71:128076.
    PubMed         Abstract available
    
    
51. HURLEY LP, Crane LA, Daley MF, Beaty B, et al
    Accuracy of self-reported vaccination status using surveys in safety-net, integrated and rural health systems in Colorado.
    Vaccine. 2025;72:128101.
    PubMed         Abstract available
    
    
52. PALPHRAMAND KL, Anderson P, Bellamy F, Birch C, et al
    Immune response to co-administration of Bacillus Calmette-Guerin (BCG) and contraceptive vaccines in badgers (Meles meles).
    Vaccine. 2025;71:128069.
    PubMed         Abstract available
    
    
53. BHATTACHARYA M, Chatterjee S, Das A, Lee SS, et al
    Machine learning (ML) and deep learning (DL) in vaccine target selection, design, development and characterization.
    Vaccine. 2025;71:128051.
    PubMed         Abstract available
    
    
54. BJORK J, Dietler D, Bonander C, Moghaddassi M, et al
    Vaccine protection against COVID-19 mortality in relation to time since last booster dose among nursing home residents in Sweden - A case-control study over 35 months.
    Vaccine. 2025;71:128043.
    PubMed         Abstract available
    
    
55. KULAPPU ARACHCHIGE SN, Abeykoon AMH, Stevenson MA, Kanci Condello A, et al
    Assessment of tracheal mucosal thicknesses is a preferable method for evaluation of the immunogenicity of Mycoplasma gallisepticum vaccines in poultry.
    Vaccine. 2025;72:128063.
    PubMed         Abstract available
    
    
56. MEYER AC, Braegelmann K, Orozco-Ruiz X, Kruppert S, et al
    Comparing uptake of high-dose and standard-dose influenza vaccination at the practice and patient level in Germany.
    Vaccine. 2025;71:128075.
    PubMed         Abstract available
    
    
57. HERNANDEZ-FRANCO JF, Abdelkhalek A, Zhang L, Ibrahium OM, et al
    Role of adjuvants in the efficacy of an IZUMO1-based immunocontraceptive vaccine in mice.
    Vaccine. 2025;72:128071.
    PubMed         Abstract available
    
    
58. GATWOOD J, Gomez-Espinosa E, Fusco N, Stempniewicz N, et al
    Real-world utilization and potential clinical and economic value of recombinant zoster vaccine and select preventive services recommended for older adults in the United States.
    Vaccine. 2025;71:128015.
    PubMed         Abstract available
    
    
59. ABEL ZDV, Roope LSJ, Violato M, Clarke PM, et al
    Corrigendum to "Accuracy of online surveys in predicting COVID-19 vaccine uptake and demand: A cohort study investigating vaccine sentiments and switching in 13 countries from 2020 to 2022" [Vaccines 62 (2025) 127450].
    Vaccine. 2025;71:128050.
    PubMed        
    
    
60. NOWZARI F, Nowzari F, Kian M, Zahedi M, et al
    Evolution and trends in non-viral mRNA Cancer vaccines: A scoping review from 2015 to 2025.
    Vaccine. 2025;71:128059.
    PubMed         Abstract available
    
    
61. ASKAR M, Adel K, Batke M, Chi Y, et al
    Population effects of influenza vaccination in children and adolescents: Systematic review.
    Vaccine. 2025;71:128040.
    PubMed         Abstract available
    
    
62. RICHARDSON RA, Moon C, Sands CM, Nelson R, et al
    Generation of a shelf-stable, broadly-reactive influenza vaccine formulated with TLR4, TLR7/8, or TLR9 stimulating adjuvants.
    Vaccine. 2025;72:128028.
    PubMed         Abstract available
    
    
63. DAMBRE C, Cornelissen L, Cuypers L, Desmet S, et al
    Pneumococcal vaccines: A dose of change. Vaccine failures and breakthrough infections in Belgian children during the PCV13 era (2019-2024).
    Vaccine. 2025;72:128065.
    PubMed         Abstract available
    
    
64. WAND H, Naidoo S, Moodley J, Govender V, et al
    Geospatial inequalities in zero-dose vaccination and structural determinants: Insights from sub-Saharan Africa (2015-2023).
    Vaccine. 2025;71:128062.
    PubMed         Abstract available
    
    
65. BUDD EL, De Anda S, Chaovalit P, Vu AH, et al
    Psychometric testing of two measures of vaccination attitudes among U.S. Latine respondents.
    Vaccine. 2025;71:128044.
    PubMed         Abstract available
    
    
66. TOWACHIRAPORN S, Thongwitokomarn H, Salee P
    The association between COVID-19 vaccination with the prevalence of post-COVID conditions in Thai patients with mild COVID-19.
    Vaccine. 2025;71:128060.
    PubMed         Abstract available
    
    
67. CHILDS L, Zoma RL, Ouedraogo I, Sawadogo G, et al
    Pneumococcal carriage among children and adults before and after a change from a three-dose 13-valent pneumococcal conjugate vaccine schedule without a booster to a two-dose schedule with a booster in Burkina Faso.
    Vaccine. 2025;72:128064.
    PubMed         Abstract available
    
    
68. SUN Z, Liu Y, Zhang H, Ge T, et al
    A novel alphavirus-based saRNA platform for enhanced vaccination efficacy and organ-specific targeting.
    Vaccine. 2025;72:128055.
    PubMed         Abstract available
    
    
69. GRACE A, Schick V, Quan FT, Troisi C, et al
    Hepatitis B vaccination series completion among residents of low-income housing in Texas: An exploratory analysis of demographic and clinical factors.
    Vaccine. 2026;70:128037.
    PubMed         Abstract available
    
    
70. SABSABI MA, Kheimar A, von La Roche D, Hartle S, et al
    B cells play an important role in HVT vaccine-mediated protection against Marek's disease virus.
    Vaccine. 2025;72:128048.
    PubMed         Abstract available
    
    

    
    Virology

71. BRICE DC, Andreev K, Miller L, Patton C, et al
    Immunogenicity and efficacy of commercial poultry avian influenza vaccines against HPAI A(H5N1) clade 2.3.4.4b viruses in Mexico.
    Virology. 2025;615:110765.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.